| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 79,555 | 88,492 | ||
| Restricted cash and cash equivalents (primarily related to vies) | 126,182 | 117,572 | ||
| Trade less allowance for credit losses of 290 and 224, respectively (primarily related to vies) | 150,066 | 154,277 | ||
| Other | 38,747 | 39,227 | ||
| Inventories | 44,604 | 44,907 | ||
| Costs and estimated earnings in excess of billings on uncompleted contracts | 23,127 | 12,926 | ||
| Prepaid expenses and other | 42,434 | 51,508 | ||
| Total current assets | 504,715 | 508,909 | ||
| Investment in unconsolidated companies | 160,369 | 160,178 | ||
| Deposits and other (primarily related to vies) | 119,873 | 102,483 | ||
| Deferred income taxes | 159,667 | 176,897 | ||
| Property, plant and equipment, net (3,364,152 and 3,271,248 related to vies, respectively) | 3,590,567 | 3,544,564 | ||
| Construction-in-process (548,991 and 251,442 related to vies, respectively) | 1,067,942 | 1,024,241 | ||
| Operating leases right of use (14,675 and 13,989 related to vies, respectively) | 35,583 | 35,240 | ||
| Financeleases right of use(none related to vies) | 4,467 | 3,648 | ||
| Intangible assets, net | 281,804 | 289,061 | ||
| Goodwill | 167,871 | 170,391 | ||
| Total assets | 6,092,858 | 6,015,612 | ||
| Accounts payable and accrued expenses | 190,079 | 212,617 | ||
| Short term revolving credit lines with banks (full recourse) | 35,000 | 96,500 | ||
| Commercial paper (less deferred financing costs of 19 and 23, respectively) | 99,981 | 99,980 | ||
| Billings in excess of costs and estimated earnings on uncompleted contracts | 32,681 | 37,693 | ||
| Limited and non-recourse (primarily related to vies) | 79,313 | 70,570 | ||
| Full recourse | 201,843 | 201,251 | ||
| Financing liability | 9,749 | 5,905 | ||
| Operating lease liabilities | 4,310 | 4,464 | ||
| Finance lease liabilities | 1,881 | 1,696 | ||
| Total current liabilities | 654,837 | 730,676 | ||
| Limited and non-recourse (primarily related to vies and less deferred financing costs of 13,208 and 8,849, respectively) | 664,321 | 542,437 | ||
| Full recourse (less deferred financing costs of 4,359 and 4,671, respectively) | 951,912 | 997,139 | ||
| Convertible senior notes (less deferred financing costs of 4,774 and 6,820, respectively) | 471,663 | 470,981 | ||
| Financing liability | 206,647 | 213,810 | ||
| Operating lease liabilities | 25,404 | 25,285 | ||
| Finance lease liabilities | 2,646 | 2,042 | ||
| Liability associated with sale of tax benefits | 195,364 | 136,778 | ||
| Deferred income taxes | 74,404 | 72,544 | ||
| Liability for unrecognized tax benefits | 7,125 | 7,583 | ||
| Liabilities for severance pay | 11,378 | 11,984 | ||
| Asset retirement obligation | 139,443 | 137,266 | ||
| Other long-term liabilities | 34,857 | 37,314 | ||
| Total liabilities | 3,440,001 | 3,385,839 | ||
| Redeemable noncontrolling interest | 9,904 | 10,985 | ||
| Common stock, par value 0.001 per share 200,000,000 shares authorized 60,781,792 and 60,500,580 issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 61 | 61 | ||
| Additional paid-in capital | 1,649,718 | 1,644,777 | ||
| Treasury stock, at cost (258,667 shares held as of september 30, 2025 and december 31, 2024, respectively) | 17,964 | 17,964 | ||
| Retained earnings | 885,233 | 868,371 | ||
| Accumulated other comprehensive income (loss) | -7,251 | -2,297 | ||
| Total stockholders' equity attributable to company's stockholders | 2,509,797 | 2,492,948 | ||
| Noncontrolling interest | 133,156 | 125,840 | ||
| Total equity | 2,642,953 | 2,618,788 | ||
| Total liabilities, redeemable noncontrolling interest and equity | 6,092,858 | 6,015,612 | ||
ORMAT TECHNOLOGIES, INC. (ORA)
ORMAT TECHNOLOGIES, INC. (ORA)